Dan Li

1PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Oct 10, 2022
Efficacy and Safety of Regorafenib with or without PD-1 Inhibitors as Second-Line Therapy for Advanced Hepatocellular Carcinoma in Real-World Clinical Practice.

Kan Liu, Jianbing Wu, Yongkang Xu

Pageof 1

Frequent Collaborators

1 joint publications

Yongkang Xu